HEADER HYDROLASE 25-JUN-13 4BV5 TITLE IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) TITLE 2 KRINGLES KIV-7, KIV-10 AND KV. COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOLIPOPROTEIN(A); COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KRINGLE IV-10, RESIDUES 4123-4201; COMPND 5 SYNONYM: APO(A), LP(A); COMPND 6 EC: 3.4.21.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: X-33; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPICZALPHA KEYWDS HYDROLASE, CARDIOVASCULAR DISEASE, OPTICAL BIOSENSORS EXPDTA X-RAY DIFFRACTION AUTHOR J.SANDMARK,M.ALTHAGE,G.M.K.ANDERSSON,T.ANTONSSON,S.BLAHO,C.BODIN, AUTHOR 2 J.BOSTROM,Y.CHEN,A.DAHLEN,P.O.ERIKSSON,E.EVERTSSON,T.FEX, AUTHOR 3 O.FJELLSTROM,D.GUSTAFSSON,C.HALLBERG,R.HICKS,E.JARKVIST,C.JOHANSSON, AUTHOR 4 I.KALIES,D.KANG,B.SVALSTEDT KARLSSON,F.KARTBERG,A.LEGNEHED, AUTHOR 5 A.M.LINDQVIST,S.A.MARTINSSON,A.MOBERG,A.U.PETERSSON,M.RIDDERSTROM, AUTHOR 6 A.THELIN,A.TIGERSTROM,J.VINBLAD,B.XU,W.KNECHT REVDAT 4 06-NOV-24 4BV5 1 REMARK REVDAT 3 20-DEC-23 4BV5 1 REMARK REVDAT 2 04-APR-18 4BV5 1 REMARK REVDAT 1 09-JUL-14 4BV5 0 JRNL AUTH J.SANDMARK,M.ALTHAGE,G.M.K.ANDERSSON,T.ANTONSSON,S.BLAHO, JRNL AUTH 2 C.BODIN,J.BOSTROM,Y.CHEN,A.DAHLEN,P.O.ERIKSSON,E.EVERTSSON, JRNL AUTH 3 T.FEX,O.FJELLSTROM,D.GUSTAFSSON,C.HALLBERG,R.HICKS, JRNL AUTH 4 E.JARKVIST,C.JOHANSSON,I.KALIES,D.KANG,B.SVALSTEDT KARLSSON, JRNL AUTH 5 F.KARTBERG,A.LEGNEHED,A.M.LINDQVIST,S.A.MARTINSSON,A.MOBERG, JRNL AUTH 6 A.U.PETERSSON,M.RIDDERSTROM,A.THELIN,A.TIGERSTROM,J.VINBLAD, JRNL AUTH 7 B.XU,W.KNECHT JRNL TITL SMALL MOLECULES USED TO DECIPHER THE PATHOPHYSIOLOGICAL JRNL TITL 2 ROLES OF THE KRINGLE DOMAINS KIV-7, - 10 AND KV OF JRNL TITL 3 APOLIPOPROTEIN(A) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 91.2 REMARK 3 NUMBER OF REFLECTIONS : 6303 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 314 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 416 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.53 REMARK 3 BIN R VALUE (WORKING SET) : 0.2880 REMARK 3 BIN FREE R VALUE SET COUNT : 21 REMARK 3 BIN FREE R VALUE : 0.3780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1258 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 57 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.29000 REMARK 3 B22 (A**2) : -0.88000 REMARK 3 B33 (A**2) : 1.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.31000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.526 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.235 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1351 ; 0.015 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1843 ; 1.751 ; 1.941 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 152 ; 5.463 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 69 ;30.215 ;22.174 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 186 ;17.315 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;18.113 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 175 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1098 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4BV5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1290057357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU A200-CU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6931 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 28.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.98000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3KIV REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 29.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG400, 0.1M CACL2, 0.1M NAOAC PH REMARK 280 4.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.62500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 0 REMARK 465 GLN B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 39 N GLU A 39 CA 0.152 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 14 37.50 -143.11 REMARK 500 ARG A 35 59.59 -103.62 REMARK 500 TYR A 41 75.01 -119.15 REMARK 500 MET A 48 -131.53 53.13 REMARK 500 ARG B 10 19.22 -140.96 REMARK 500 SER B 14 38.77 -140.28 REMARK 500 ARG B 35 54.48 -98.54 REMARK 500 MET B 48 -127.67 48.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU A 39 -13.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5C3 A 1081 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5C3 B 1081 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BV7 RELATED DB: PDB REMARK 900 IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) REMARK 900 KRINGLES KIV-7, KIV-10 AND KV. REMARK 900 RELATED ID: 4BVC RELATED DB: PDB REMARK 900 IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) REMARK 900 KRINGLES KIV-7, KIV-10 AND KV. REMARK 900 RELATED ID: 4BVD RELATED DB: PDB REMARK 900 IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) REMARK 900 KRINGLES KIV-7, KIV-10 AND KV. REMARK 900 RELATED ID: 4BVV RELATED DB: PDB REMARK 900 IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) REMARK 900 KRINGLES KIV-7, KIV-10 AND KV. REMARK 900 RELATED ID: 4BVW RELATED DB: PDB REMARK 900 IDENTIFICATION OF SMALL MOLECULE INHIBITORS SELECTIVE FOR APO(A) REMARK 900 KRINGLES KIV-7, KIV-10 AND KV. REMARK 999 REMARK 999 SEQUENCE REMARK 999 KRINGLE IV-10 DOMAIN, N76A MUTATION DBREF 4BV5 A 0 80 UNP P08519 APOA_HUMAN 4123 4201 DBREF 4BV5 B 0 80 UNP P08519 APOA_HUMAN 4123 4201 SEQADV 4BV5 ALA A 76 UNP P08519 ASN 4197 ENGINEERED MUTATION SEQADV 4BV5 ALA B 76 UNP P08519 ASN 4197 ENGINEERED MUTATION SEQRES 1 A 79 GLN CYS TYR HIS GLY ASN GLY GLN SER TYR ARG GLY THR SEQRES 2 A 79 PHE SER THR THR VAL THR GLY ARG THR CYS GLN SER TRP SEQRES 3 A 79 SER SER MET THR PRO HIS ARG HIS GLN ARG THR PRO GLU SEQRES 4 A 79 ASN TYR PRO ASN ASP GLY LEU THR MET ASN TYR CYS ARG SEQRES 5 A 79 ASN PRO ASP ALA ASP THR GLY PRO TRP CYS PHE THR MET SEQRES 6 A 79 ASP PRO SER ILE ARG TRP GLU TYR CYS ALA LEU THR ARG SEQRES 7 A 79 CYS SEQRES 1 B 79 GLN CYS TYR HIS GLY ASN GLY GLN SER TYR ARG GLY THR SEQRES 2 B 79 PHE SER THR THR VAL THR GLY ARG THR CYS GLN SER TRP SEQRES 3 B 79 SER SER MET THR PRO HIS ARG HIS GLN ARG THR PRO GLU SEQRES 4 B 79 ASN TYR PRO ASN ASP GLY LEU THR MET ASN TYR CYS ARG SEQRES 5 B 79 ASN PRO ASP ALA ASP THR GLY PRO TRP CYS PHE THR MET SEQRES 6 B 79 ASP PRO SER ILE ARG TRP GLU TYR CYS ALA LEU THR ARG SEQRES 7 B 79 CYS HET 5C3 A1081 20 HET 5C3 B1081 20 HETNAM 5C3 4-(AMINOMETHYL)-N-(BENZENESULFONYL) HETNAM 2 5C3 CYCLOHEXANECARBOXAMIDE FORMUL 3 5C3 2(C14 H20 N2 O3 S) FORMUL 5 HOH *57(H2 O) SHEET 1 AA 2 TRP A 62 PHE A 64 0 SHEET 2 AA 2 TRP A 72 TYR A 74 -1 O GLU A 73 N CYS A 63 SHEET 1 BA 2 TRP B 62 PHE B 64 0 SHEET 2 BA 2 TRP B 72 TYR B 74 -1 O GLU B 73 N CYS B 63 SSBOND 1 CYS A 1 CYS A 80 1555 1555 2.04 SSBOND 2 CYS A 22 CYS A 63 1555 1555 2.01 SSBOND 3 CYS A 51 CYS A 75 1555 1555 2.03 SSBOND 4 CYS B 1 CYS B 80 1555 1555 2.05 SSBOND 5 CYS B 22 CYS B 63 1555 1555 2.01 SSBOND 6 CYS B 51 CYS B 75 1555 1555 2.02 CISPEP 1 THR A 29 PRO A 30 0 6.10 CISPEP 2 THR B 29 PRO B 30 0 1.57 SITE 1 AC1 12 HIS A 33 GLN A 34 ARG A 35 ASP A 55 SITE 2 AC1 12 ASP A 57 TRP A 62 PHE A 64 ARG A 71 SITE 3 AC1 12 TRP A 72 ASP B 67 PRO B 68 SER B 69 SITE 1 AC2 11 ASP A 67 PRO A 68 SER A 69 HIS B 33 SITE 2 AC2 11 GLN B 34 ARG B 35 ASP B 55 ASP B 57 SITE 3 AC2 11 TRP B 62 ARG B 71 TRP B 72 CRYST1 24.410 45.250 56.100 90.00 90.67 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.040967 0.000000 0.000479 0.00000 SCALE2 0.000000 0.022099 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017827 0.00000 MTRIX1 1 0.999900 0.000098 0.013790 11.90170 1 MTRIX2 1 0.000096 -1.000000 0.000151 25.70490 1 MTRIX3 1 0.013790 -0.000150 -0.999900 28.12560 1